These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. C-reactive protein and response to lurasidone in patients with bipolar depression. Raison CL; Pikalov A; Siu C; Tsai J; Koblan K; Loebel A Brain Behav Immun; 2018 Oct; 73():717-724. PubMed ID: 30102967 [TBL] [Abstract][Full Text] [Related]
6. ECNP consensus meeting. Bipolar depression. Nice, March 2007. Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566 [TBL] [Abstract][Full Text] [Related]
7. Plasma C-reactive protein levels in bipolar depression during cyclooxygenase-2 inhibitor combination treatment. Edberg D; Hoppensteadt D; Walborn A; Fareed J; Sinacore J; Halaris A J Psychiatr Res; 2018 Jul; 102():1-7. PubMed ID: 29554535 [TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory agents in the treatment of bipolar depression: a systematic review and meta-analysis. Rosenblat JD; Kakar R; Berk M; Kessing LV; Vinberg M; Baune BT; Mansur RB; Brietzke E; Goldstein BI; McIntyre RS Bipolar Disord; 2016 Mar; 18(2):89-101. PubMed ID: 26990051 [TBL] [Abstract][Full Text] [Related]
9. Treatment of bipolar depression with minocycline and/or aspirin: an adaptive, 2×2 double-blind, randomized, placebo-controlled, phase IIA clinical trial. Savitz JB; Teague TK; Misaki M; Macaluso M; Wurfel BE; Meyer M; Drevets D; Yates W; Gleason O; Drevets WC; Preskorn SH Transl Psychiatry; 2018 Jan; 8(1):27. PubMed ID: 29362444 [TBL] [Abstract][Full Text] [Related]
10. C-reactive protein: A differential biomarker for major depressive disorder and bipolar II disorder. Chang HH; Wang TY; Lee IH; Lee SY; Chen KC; Huang SY; Yang YK; Lu RB; Chen PS World J Biol Psychiatry; 2017 Feb; 18(1):63-70. PubMed ID: 26895280 [TBL] [Abstract][Full Text] [Related]
11. A pilot, open-label, 8-week study evaluating the efficacy, safety and tolerability of adjunctive minocycline for the treatment of bipolar I/II depression. Soczynska JK; Kennedy SH; Alsuwaidan M; Mansur RB; Li M; McAndrews MP; Brietzke E; Woldeyohannes HO; Taylor VH; McIntyre RS Bipolar Disord; 2017 May; 19(3):198-213. PubMed ID: 28599348 [TBL] [Abstract][Full Text] [Related]
12. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
13. Anti-inflammatory treatment of bipolar depression: promise and disappointment. Berk M; Vieta E; Dean OM Lancet Psychiatry; 2020 Jun; 7(6):467-468. PubMed ID: 32445674 [No Abstract] [Full Text] [Related]
14. Association of depression and obesity with C-reactive protein in Germany: A large nationally representative study. Chae WR; Nübel J; Baumert J; Gold SM; Otte C Brain Behav Immun; 2022 Jul; 103():223-231. PubMed ID: 35491003 [TBL] [Abstract][Full Text] [Related]
15. The association between low-grade inflammation and the clinical features of bipolar disorder in Han Chinese population. Gan Z; Wu X; Liao Y; Wu Y; He Z; Yang Z; Zhang Q Psychoneuroendocrinology; 2019 Mar; 101():286-294. PubMed ID: 30597323 [TBL] [Abstract][Full Text] [Related]
16. Bipolar symptoms, somatic burden, and functioning in older-age bipolar disorder: Analyses from the Global Aging & Geriatric Experiments in Bipolar Disorder Database project. Sajatovic M; Dols A; Rej S; Almeida OP; Beunders AJM; Blumberg HP; Briggs FBS; Forester BP; Patrick RE; Forlenza OV; Gildengers A; Jimenez E; Vieta E; Mulsant B; Schouws S; Paans N; Strejilevich S; Sutherland A; Tsai S; Wilson B; Eyler LT Bipolar Disord; 2022 Mar; 24(2):195-206. PubMed ID: 34314549 [TBL] [Abstract][Full Text] [Related]
18. Association between C-reactive protein (CRP) with depression symptom severity and specific depressive symptoms in major depression. Köhler-Forsberg O; Buttenschøn HN; Tansey KE; Maier W; Hauser J; Dernovsek MZ; Henigsberg N; Souery D; Farmer A; Rietschel M; McGuffin P; Aitchison KJ; Uher R; Mors O Brain Behav Immun; 2017 May; 62():344-350. PubMed ID: 28257825 [TBL] [Abstract][Full Text] [Related]
19. Cardiometabolic risk in young adults with depression and evidence of inflammation: A birth cohort study. Perry BI; Oltean BP; Jones PB; Khandaker GM Psychoneuroendocrinology; 2020 Jun; 116():104682. PubMed ID: 32339985 [TBL] [Abstract][Full Text] [Related]